The health and safety of our patients, families and staff is our highest priority. Due to the COVID-19 pandemic, the Commonwealth of Massachusetts is requiring hospitals to meet established criteria as part of the state’s reopening plan. The Boston Shriners Hospital completed its Phase 1 attestation on May 27, 2020, and its Phase 2 attestation on June 15, 2020 and its Phase 3 attestation on July 13, 2020. The Phase 3 attestation was resubmitted and reaffirmed on November 16, 2020. The Boston Shriners Hospital also completed and submitted the state’s resurgence attestation on November 16, 2020.

If your child has an upcoming appointment, please contact your local Shriners Hospitals for Children location.

Shriners Hospitals for Children — Boston visitor information.

Skip to navigation

Martin L. Yarmush, M.D., Ph.D.

Martin L. Yarmush, M.D., Ph.D.

Martin Yarmush, M.D., Ph.D., is the director of the Center for Engineering in Medicine at the Massachusetts General Hospital and Shriners Hospitals for Children — Boston, and oversees multiple shared facilities, including the Imaging and Morphology Core and the Genomics and Proteomics Core.

Dr. Yarmush is an internationally recognized bioengineer and translational scientist whose laboratory has been a pioneer and leader in multiple fields, including burn injury and wound healing, tissue engineering and regenerative medicine, hypermetabolism in severe injury, applied immunology and biotechnology, and BioMEMS and medical devices. Among his current projects are the following: new nanoparticle technology to enhance wound healing; microfabricated tissue-on-a-chip-systems to study wound healing response; pulsed electric field techniques to promote scarless wound healing and wound disinfection; organ re-engineering through recellularization of decellularized scaffolds and revitalization perfusion of marginal organs; supercooled preservation of cells, tissues, and organs; encapsulated mesenchymal stem cells for treatment of spinal cord injury and osteoarthritis; and development of an automated robotic venipuncture device with point-of-care capabilities.

Over the last 30+ years, Dr. Yarmush has published more than 490 refereed journal articles, and has co-authored more than 50 patents and patent applications. Dr. Yarmush has been PI or co-PI on numerous Shriners Research, NIH, NSF, DoD Grants, and, as well as several Center and Consortium research grants from governmental and foundation agencies.  

Dr. Yarmush is the recipient of numerous awards throughout his career. His most recent awards include:

  • Top 20 Translational Researchers, Nature Biotechnology (2013)
  • Robert A. Pritzker Distinguished Lecture Award from the Board of Directors of BMES (2015)
  • Fellow, US National Academy of Inventors (2015)
  • Fellow, US National Academy of Engineering (2017)

Dr. Yarmush is also editor-in-chief of several journals, including Annual Reviews of Biomedical Engineering, Technology and NanoLIFE.

Current positions:

  • Senior Investigator, Shriners Hospitals for Children — Boston
  • Lecturer in Surgery and Bioengineering (formerly the Helen Andrus Benedict Professor of Surgery and Bioengineering, Harvard-MIT Division of Health Sciences and Technology), Harvard Medical School
  • Director, Center for Engineering in Medicine, Massachusetts General Hospital (MGH)


  • BA, Biology/Chemistry, Yeshiva University, New York, N.Y.
  • Ph.D., Biophysical Chemistry, The Rockefeller University, New York, N.Y.
  • Ph.D. Studies, Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Mass.
  • M.D., Yale University, New Haven, Conn.
  • Postdoctoral, Immunology and Immunogenetics, National Institutes of Health, Bethesda, Md.

Scholarly activities: